Seelos Therapeutics, Inc. (SEELQ) vs ZyVersa Therapeutics, Inc. (ZVSA)

Seelos Therapeutics, Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. ZyVersa Therapeutics, Inc. is the larger, with a market value of $970.0K against $700.0K — 1.4× the size. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Seelos Therapeutics, Inc. leads on 7 and ZyVersa Therapeutics, Inc. on 4.

Valuation

Metric SEELQ ZVSA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.50 n/m 10.73
Earnings yield 0.00% (3,679.60%) (28.84%)
Free cash flow yield 0.00% (511.54%) (23.03%)

Profitability

Metric SEELQ ZVSA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,480.04%) 0.00% 0.00%
Net margin 203.13% 0.00% 0.00%
Free cash flow margin (659.09%) 0.00% 0.00%
Return on equity (10.86%) 817.13% (57.72%)
Return on assets 57.34% (225.42%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SEELQ ZVSA Biotechnology median
Revenue growth (TTM) (51.45%) — 5.64%
EPS growth (last fiscal year) 62.72% 50.71% —
Revenue growth, 5-year CAGR (22.63%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SEELQ ZVSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.08 0.05 4.73
Net debt to EBITDA 0.09 0.00 0.96

Dividend

Metric SEELQ ZVSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric SEELQ ZVSA Biotechnology median
Market cap 700.00k 970.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack